Newsroom
Home > Newsroom
340B In The News
October 2, 2017
In Case You Missed It: New Report Finds Cancer Treatment in Hospitals More Expensive Than in Community Practice Settings
WASHINGTON -- The Community Oncology Alliance (COA) released a report last week on the costs of cancer treatment depending on the site of care. The report found that across various types of cancer profiles, the cost of cancer care for patients treated in the community clinic setting is about $8,000 less expensive per month than treatment in the hospital-based setting.* Looked at another way, the total cost of care for cancer patients receiving chemotherapy delivered in the hospital outpatient setting is nearly 60 percent, or $90,144, per year more expensive than the same treatment delivered in independent, community oncology practices.
340B In The News
October 2, 2017
“Getting 340B Drug Discount Program Back on Track”
While not yet in the limelight of healthcare discussions, and totally unknown to most people, the federal 340B drug discount program affects many vulnerable patients in Southwestern Illinois. Created in 1992 to help vulnerable or uninsured patients afford valuable medications by providing certain hospitals and safety net clinics with discounted medicine, the 340B program is no longer functioning as intended.
340B In The News
October 2, 2017
“Drug Discount Program Needs Reform”
Drug Discount Program Needs Reform
340B In The News
September 27, 2017
“Congress Must Fix the Broken 340B Drug Pricing Program that Benefits Hospitals, Starves the Poor”
Too often government programs start with a noble goal but are soon denigrated by special interests groups who use well intentioned programs for their own gain. Unfortunately, this has happened with the 340B drug discount program. Due to limited oversight, bad actors have been able to profit from this federal program, abusing the system and hurting the exact people the program was intended to help.
340B In The News
September 25, 2017
“Drug Discount Programs Have Become Wasteful – They Don’t Help Patients”
There are many reasons why the cost of health care is rising, including massive and unchecked federal programs that have proliferated throughout the entire health-care system. The 340B drug discount program is among those that must be examined and reined in.
340B In The News
September 21, 2017
RealClearPolicy: The Trump Administration is Right to Reform 340B
As government grows, so does abuse and cronyism. The 340B drug-pricing program is a textbook example of how insiders, lobbyists, and influence-peddlers high-jacked an obscure provision of law and turned it into a profit-making racket. Now that the Trump administration is trying to reform the program, the K-Street set is coming out in force to defend it.
340B In The News
September 19, 2017
In Case You Missed It: Washington Hospitals Falling Short on Charity Care, Potentially Discriminating Against Latino Patients
The Seattle Times recently wrote on a report conducted by Columbia Legal Services (CLS) that found a record number of hospitals are withholding charity care throughout the state of Washington. 27 of the hospitals referenced are 340B Drug Discount Program covered entities, a program which was designed to help certain health care safety-net providers that serve uninsured or otherwise vulnerable patients reduce outpatient prescription drug costs, giving entities the ability to increase uncompensated and charity care in their local communities.